메뉴 건너뛰기




Volumn 6, Issue 5, 2004, Pages 673-676

Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy

Author keywords

BETACAR; BRING UP 2 VAS; Cardiac resynchronisation therapy; CASINO; COLA II; FOSIDIAL; SHAPE

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; FOSINOPRIL; LEVOSIMENDAN; METOPROLOL TARTRATE; PLACEBO; SPIRONOLACTONE;

EID: 4043171309     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.07.007     Document Type: Conference Paper
Times cited : (65)

References (6)
  • 1
    • 17944374924 scopus 로고    scopus 로고
    • Task force for the diagnosis and treatment of chronic heart failure, ESC: Guidelines for the diagnosis and treatment of chronic heart failure
    • Remme W.J., Swedberg K. Task force for the diagnosis and treatment of chronic heart failure, ESC: guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22:2001;1527-1560
    • (2001) Eur. Heart J. , vol.22 , pp. 1527-1560
    • Remme, W.J.1    Swedberg, K.2
  • 2
    • 2442493096 scopus 로고    scopus 로고
    • Tolerability of carvedilol in heart failure: Clinical trials experience
    • (Suppl.)
    • Krum H. Tolerability of carvedilol in heart failure: clinical trials experience. Am. J. Cardiol. 93:2004;58B-63B. (Suppl.)
    • (2004) Am. J. Cardiol. , vol.93
    • Krum, H.1
  • 3
    • 0036434418 scopus 로고    scopus 로고
    • FOSIDIAL: A randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patient's baseline characteristics
    • Zannad F., Kessler M., Grunfeld J.P., Thuilliez C. FOSIDIAL investigators FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patient's baseline characteristics. Fundam. Clin. Pharmacol. 16:2002;353-360
    • (2002) Fundam. Clin. Pharmacol. , vol.16 , pp. 353-360
    • Zannad, F.1    Kessler, M.2    Grunfeld, J.P.3    Thuilliez, C.4
  • 4
    • 3142776467 scopus 로고    scopus 로고
    • Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the COMET trial
    • Poole-Wilson P.A., et al. for the COMET investigators Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the COMET trial. Lancet. 362:2003;7-13
    • (2003) Lancet , vol.362 , pp. 7-13
    • Poole-Wilson, P.A.1
  • 5
    • 0032894346 scopus 로고    scopus 로고
    • Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design
    • Bohler S., Saubadu S., Scheldewaert R., Figulla H.R. Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design. Arzneimittelforschung. 49:1999;311-317
    • (1999) Arzneimittelforschung , vol.49 , pp. 311-317
    • Bohler, S.1    Saubadu, S.2    Scheldewaert, R.3    Figulla, H.R.4
  • 6
    • 2942556913 scopus 로고    scopus 로고
    • Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-LIPIDS, and cardiac resynchronisation therapy in heart failure
    • Cleland J.G.F., Ghosh J., Freemantle N., et al. Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-LIPIDS, and
    • (2004) Eur. J. Heart Fail. , vol.6 , pp. 501-508
    • Cleland, J.G.F.1    Ghosh, J.2    Freemantle, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.